Torrent Pharmaceuticals saw its stock rise by 2.37% to ₹3,178.15 after the United States Food and Drug Administration (USFDA) issued an Establishment Inspection Report (EIR) with a 'Voluntary Action Indicated' (VAI) classification for its manufacturing facility located in Pithampur, Madhya Pradesh.
The inspection, which took place from 16 to 20 September 2024, concluded with a…
